(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 22.87%155.53B | 25.01%73.28B | 25.82%276.74B | 27.04%203.05B | 30.22%126.58B | 26.69%58.62B | 22.79%219.95B | 23.32%159.83B | 20.34%97.21B | 25.00%46.27B |
Operating income | 22.87%155.53B | 25.01%73.28B | 25.82%276.74B | 27.04%203.05B | 30.22%126.58B | 26.69%58.62B | 22.79%219.95B | 23.32%159.83B | 20.34%97.21B | 25.00%46.27B |
Cost of sales | -17.91%-95.94B | -22.63%-47.58B | -13.50%-179.55B | -13.78%-130.85B | -14.77%-81.37B | -9.21%-38.8B | -15.77%-158.2B | -16.04%-115.01B | -16.10%-70.89B | -19.16%-35.53B |
Operating expenses | -17.91%-95.94B | -22.63%-47.58B | -13.50%-179.55B | -13.78%-130.85B | -14.77%-81.37B | -9.21%-38.8B | -15.77%-158.2B | -16.04%-115.01B | -16.10%-70.89B | -19.16%-35.53B |
Gross profit | 31.78%59.59B | 29.67%25.7B | 57.39%97.19B | 61.09%72.2B | 71.83%45.22B | 84.51%19.82B | 45.39%61.75B | 46.99%44.82B | 33.49%26.31B | 49.17%10.74B |
Selling expenses | -14.95%-28.72B | -33.12%-13.89B | -47.48%-58.62B | -44.56%-41.89B | -38.11%-24.99B | -14.58%-10.43B | 2.31%-39.75B | 1.58%-28.98B | -0.20%-18.09B | -26.36%-9.11B |
Administrative expenses | -20.79%-4.99B | -15.21%-2.3B | 4.09%-9.37B | 8.87%-6.67B | 14.16%-4.13B | 13.72%-1.99B | -13.46%-9.77B | -18.51%-7.32B | -27.05%-4.82B | -33.09%-2.31B |
Research and development expenses | 1.10%-10.34B | 0.94%-5B | -2.22%-21.2B | -1.80%-15.78B | -3.69%-10.45B | -3.45%-5.05B | -24.37%-20.74B | -28.14%-15.5B | -36.66%-10.08B | -40.31%-4.88B |
Revaluation surplus | -337.93%-637.15M | -415.26%-517.12M | 123.12%234.23M | 124.64%295.88M | 124.45%267.79M | 120.43%164.03M | -224.19%-1.01B | -1,452.60%-1.2B | -629.58%-1.1B | -2,010.11%-802.89M |
-Changes in the fair value of other assets | -337.93%-637.15M | -415.26%-517.12M | 123.12%234.23M | 124.64%295.88M | 124.45%267.79M | 120.43%164.03M | -224.19%-1.01B | -1,452.60%-1.2B | -629.58%-1.1B | -2,010.11%-802.89M |
Impairment and provision | -0.27%-451.82M | 31.31%-175.39M | -142.29%-1.14B | -49.04%-726.99M | -121.16%-450.61M | -66.55%-255.35M | -80.27%-468.62M | -135.12%-487.79M | -188.68%-203.75M | -553.93%-153.32M |
-Other impairment is provision | -0.27%-451.82M | 31.31%-175.39M | -142.29%-1.14B | -49.04%-726.99M | -121.16%-450.61M | -66.55%-255.35M | -80.27%-468.62M | -135.12%-487.79M | -188.68%-203.75M | -553.93%-153.32M |
Special items of operating profit | -28.81%2.02B | 4.26%1.39B | 51.63%6.32B | 18.26%4.23B | 49.74%2.84B | 43.75%1.34B | 2,342.47%4.17B | 558.68%3.58B | 40.01%1.9B | 145.62%928.73M |
Operating profit | 98.42%16.47B | 45.28%5.21B | 330.49%13.42B | 329.07%11.66B | 236.56%8.3B | 164.21%3.59B | 74.83%-5.82B | 71.92%-5.09B | 24.21%-6.08B | -17.14%-5.58B |
Financing income | 55.44%624.25M | 51.70%279.76M | 24.48%818.99M | 18.08%602.83M | 33.53%401.61M | 67.11%184.42M | 20.49%657.91M | 31.28%510.52M | 58.32%300.77M | 41.75%110.36M |
Financing cost | 14.17%-607.24M | 8.94%-321.86M | 12.50%-1.43B | 13.50%-1.06B | 5.53%-707.48M | -7.01%-353.48M | -44.02%-1.63B | -53.10%-1.22B | -74.44%-748.93M | -98.92%-330.32M |
Special items of earning before tax | 802.17%655.4M | 731.44%314.2M | 3,282.76%1.21B | 285.03%507.17M | 120.54%72.65M | -207.21%-49.76M | -75.38%35.85M | -57.44%131.72M | -1,075.88%-353.64M | 2,405.56%46.41M |
Earning before tax | 112.49%17.14B | 62.80%5.48B | 307.56%14.02B | 306.49%11.71B | 217.25%8.07B | 158.48%3.37B | 71.33%-6.76B | 68.88%-5.67B | 16.33%-6.88B | -18.54%-5.76B |
Tax | -2,170.46%-417.38M | -1,237.56%-112.5M | -334.40%-164.54M | -199.98%-68.48M | -130.49%-18.38M | -115.23%-8.41M | 131.82%70.19M | 171.58%68.5M | 214.24%60.29M | 404.09%55.22M |
After-tax profit from continuing operations | 107.79%16.72B | 59.86%5.37B | 307.28%13.86B | 307.80%11.64B | 218.02%8.05B | 158.89%3.36B | 71.60%-6.69B | 69.22%-5.6B | 16.87%-6.82B | -17.67%-5.7B |
Earning after tax | 107.79%16.72B | 59.86%5.37B | 307.28%13.86B | 307.80%11.64B | 218.02%8.05B | 158.89%3.36B | 71.60%-6.69B | 69.22%-5.6B | 16.87%-6.82B | -17.67%-5.7B |
Minority profit | -14.80%858K | 70.93%441K | 90.98%1.5M | 55.36%1.22M | 142.65%1.01M | 435.06%258K | -63.92%787K | -64.67%784K | -78.92%415K | -107.54%-77K |
Profit attributable to shareholders | 107.81%16.72B | 59.86%5.37B | 307.23%13.86B | 307.75%11.64B | 218.00%8.05B | 158.89%3.36B | 71.59%-6.69B | 69.22%-5.6B | 16.89%-6.82B | -17.64%-5.7B |
Basic earnings per share | 107.69%2.7 | 304.59%2.23 | 217.12%1.3 | 72.05%-1.09 | 19.57%-1.11 | |||||
Diluted earnings per share | 113.22%2.58 | 293.58%2.11 | 209.01%1.21 | 72.05%-1.09 | 19.57%-1.11 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data